Andrea Tu, Author at Bolt Biotherapeutics

Press Release

Bolt Biotherapeutics Appoints Dr. Nils Lonberg to its Scientific Advisory [...]

By Andrea Tu|2020-08-27T18:46:21-07:00February 20, 2020|press release|Comments Off

Bolt invited to present: SVB Leerink 9th Annual Global Healthcare [...]

By Andrea Tu|2020-08-27T20:12:50-07:00February 4, 2020|events|Comments Off

Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. [...]

By Andrea Tu|2020-08-27T18:49:24-07:00January 9, 2020|press release|Comments Off

Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate [...]

By Andrea Tu|2020-11-10T20:38:09-08:00November 10, 2019|publications|Comments Off

Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives [...]

By Andrea Tu|2020-11-10T20:40:58-08:00November 10, 2019|publications|Comments Off

Systemically administered HER2-targeted ISACs provoke a rapid, local response that [...]

By Andrea Tu|2020-11-10T20:55:21-08:00November 10, 2019|publications|Comments Off

Bolt Biotherapeutics Presents Data At SITC Conference Showing Eradication of [...]

By Andrea Tu|2020-08-27T18:49:48-07:00November 9, 2019|press release|Comments Off

HER2-targeting TLR 7/8 immune-stimulating antibody conjugates elicit robust myeloid activation [...]

By Andrea Tu|2020-10-12T13:13:27-07:00November 6, 2019|publications|Comments Off

Bolt invited to present: SITC Nov 6-10, 2019National Harbor, MD

By Andrea Tu|2020-08-27T20:14:08-07:00October 12, 2019|events|Comments Off

Bolt Strengthens Scientific Advisory Board Through Addition of Drs. Lawrence [...]

By Andrea Tu|2020-08-27T18:50:55-07:00October 8, 2019|press release|Comments Off